clarithromycin has been researched along with Cancer of Lung in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (43.90) | 18.2507 |
2000's | 15 (36.59) | 29.6817 |
2010's | 8 (19.51) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butković, K; Ćaleta, I; Dukši, M; Hlevnjak, M; Koštrun, S; Kragol, G; Makaruha-Stegić, O; Malnar, I; Mikac, L; Munić, V; Ralić, J; Stepanić, V; Tatić, I; Tavčar, B; Valko, K; Zulfikari, S | 1 |
Ghadiri, M; Lee, WH; Leong, CR; Loo, CY; Traini, D; Young, PM | 1 |
Funaishi, K; Hattori, N; Ishiyama, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Saito, N; Sakamoto, KI; Taniwaki, M; Yamasaki, M | 1 |
Daimon, T; Eto, T; Hatori, M; Hayashi, H; Ikeda, M; Inoue, K; Itoh, K; Kamezato, M; Taku, K; Tsuji, D | 1 |
Che, XF; Hiramoto, M; Ito, K; Miyazawa, K; Moriya, S; Sugita, S; Yamashiro, Y; Yokoyama, T | 1 |
Awan, S; Baldwin, D; Crosby, V; Hennig, I; Ndlovu, M; Paradine, S; Potter, V; Wilcock, A | 1 |
Igarashi, T; Masada, M; Nakamura, T; Tani, D; Tsukamoto, H; Watanabe, K; Yano, R | 1 |
Amenomori, M; Fujita, H; Hara, A; Hara, S; Harada, T; Hayashi, T; Ishimatsu, Y; Kohno, S; Matsumoto, K; Mukae, H; Sakamoto, N | 1 |
Ferreri, AJM | 1 |
Sugiyama, Y | 1 |
Ii, T; Kato, S; Matsumoto, R; Mukai, H; Sano, A; Tokoshima, M | 1 |
Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, H; Sano, M; Sasaki, M | 1 |
Blum, S; Sauter, C | 1 |
Mikasa, K | 2 |
Arao, T; Hirama, N; Inoue, S; Kubota, I; Machiya, J; Sata, M; Sato, J; Shibata, Y; Takabatake, N; Tokairin, Y; Wada, T | 1 |
Bagarazzi, ML; Hogarty, M; Kim, IK; McGowan, KL; Watson, B | 1 |
Hamada, K; Kita, E; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S | 1 |
Hara, N; Hayashi, S; Turuta, N; Wakamatsu, K; Yatsunami, J | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, M; Tsujimoto, M | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M | 3 |
Aoyama, S; Azuma, A; Hino, M; Kokubo, Y; Kudo, S; Matsuda, K; Shibuya, M; Shu, D | 1 |
Goto, G; Ieshiro, R; Iguchi, M; Okamura, J; Ota, T; Yuasa, K | 2 |
Fukuoka, K; Hamada, K; Kataoka, T; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Segawa, K; Teramoto, S; Tsujimoto, M; Ueda, K | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S; Tsujimoto, M; Ueta, K | 1 |
Aoyama, S; Hino, M; Kokubo, Y; Kudo, S; Kyo, D; Matsuda, K; Shibuya, M; Wagatsuma, A | 1 |
Akashi, T; Sone, S; Yamagishi, T; Yano, S | 1 |
Inoue, K; Matsuo, H; Nishi, Y; Sakamoto, Y; Sakata, K; Shibazaki, M | 1 |
Ashitani, J; Hiratsuka, T; Hirosako, S; Ihiboshi, H; Katoh, S; Mashimoto, H; Matsukura, S; Matsumoto, M; Mizobe, T; Mukae, H | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Ueda, K; Yoshimoto, E | 1 |
Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E | 1 |
Narita, N | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, S; Yoshimoto, E | 1 |
Ichiki, K; Kimura, M; Shishizawa, Y; Yoshida, S | 1 |
Konishi, Y; Mikasa, K; Murakawa, Y; Murata, N; Narita, N; Sasaki, Y; Tsujiuchi, T; Tsutsumi, M | 1 |
Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, M; Sano, M; Sasaki, M; Watanabe, A | 1 |
Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M | 1 |
4 review(s) available for clarithromycin and Cancer of Lung
Article | Year |
---|---|
The potential to treat lung cancer via inhalation of repurposed drugs.
Topics: Administration, Inhalation; Antineoplastic Agents; Clarithromycin; Drug Repositioning; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Lung Neoplasms | 2018 |
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections | 2002 |
[Clinical application of the new action of macrolide preparations to respiratory diseases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms | 1999 |
"Multi-effect" macrolides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bronchiolitis; Clarithromycin; Humans; Lung Neoplasms; Macrolides | 2000 |
5 trial(s) available for clarithromycin and Cancer of Lung
Article | Year |
---|---|
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Middle Aged | 1997 |
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer--the second report].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Survival Rate | 1998 |
[Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-6; Lung Neoplasms; Male; Middle Aged | 1998 |
[Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Clarithromycin; Cytokines; Female; Humans; Immunologic Factors; Killer Cells, Natural; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 2000 |
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
Topics: Aged; Biomarkers; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Combined Modality Therapy; Disease Progression; Female; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Protein Synthesis Inhibitors; Survival Analysis; Treatment Outcome; Weight Gain | 2001 |
32 other study(ies) available for clarithromycin and Cancer of Lung
Article | Year |
---|---|
Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties.
Topics: Cell Line, Tumor; Chemical Phenomena; Humans; Leukocytes; Lung; Lung Neoplasms; Macrolides; Models, Biological; Primary Cell Culture; Respiratory Mucosa; Structure-Activity Relationship | 2011 |
Small-Cell Lung Cancer Comorbid with Pulmonary Mycobacterium avium Infection: A Case Report.
Topics: Aged; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Bronchoscopy; Clarithromycin; Drug Therapy, Combination; Etoposide; Humans; Lung; Lung Neoplasms; Male; Mycobacterium avium; Peptide Fragments; Recombinant Proteins; Rifampin; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Tuberculosis, Avian | 2018 |
Retrospective analysis of severe neutropenia in patients receiving concomitant administration of docetaxel and clarithromycin.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Odds Ratio; Retrospective Studies; Severity of Illness Index; Sex Factors; Taxoids | 2013 |
EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Clarithromycin; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Treatment Outcome | 2015 |
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study.
Topics: Anti-Bacterial Agents; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Feasibility Studies; Female; Humans; Lung Neoplasms; Macrolides; Male; Medication Adherence; Neoplasm Staging; Placebos; Randomized Controlled Trials as Topic | 2017 |
Evaluation of potential interaction between vinorelbine and clarithromycin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Cohort Studies; Drug Interactions; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Sex Characteristics; Vinblastine; Vinorelbine | 2009 |
Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Respiratory Mucosa | 2010 |
Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic?
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Chlamydophila; Chlamydophila Infections; Clarithromycin; Helicobacter; Helicobacter Infections; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Treatment Outcome | 2011 |
[Case of pulmonary MALT lymphoma successfully treated with clarithromycin].
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Treatment Outcome | 2001 |
[Effect of 14-membered ring macrolides on heparanase mRNA expression in lung cancer cells].
Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Platelet-Derived Growth Factor; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Female; Hodgkin Disease; Humans; Lung Neoplasms; Reed-Sternberg Cells | 2003 |
[New treatment not based on MIC for infectious diseases--making use of experience of macrolide long-term therapy].
Topics: Adult; Aged; Aged, 80 and over; Animals; Bronchiectasis; Bronchitis, Chronic; Clarithromycin; Erythromycin; Female; Humans; Lung Neoplasms; Macrolides; Male; Mice; Middle Aged | 2005 |
Clarithromycin suppresses invasiveness of human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Clarithromycin; Humans; Integrin alpha2; Integrin beta1; Lung Neoplasms; Mice; Neoplasm Invasiveness; NIH 3T3 Cells; Thymidine Phosphorylase | 2007 |
Pulmonary Mycobacterium gordonae infection in a two-year-old child: case report.
Topics: Antitubercular Agents; Biopsy; Cefuroxime; Child, Preschool; Clarithromycin; Endodermal Sinus Tumor; Female; Humans; Lung Neoplasms; Mycobacterium Infections; Nontuberculous Mycobacteria; Tomography, X-Ray Computed | 1996 |
Clarithromycin is a potent inhibitor of tumor-induced angiogenesis.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Clarithromycin; Humans; Lung Neoplasms; Mice; Neoplasms, Experimental; Neovascularization, Pathologic | 1997 |
[Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Female; Immunologic Factors; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred Strains | 1997 |
[Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-6; Lung Neoplasms; Male; Tumor Necrosis Factor-alpha | 1997 |
[Effects of clarithromycin on experimental pulmonary metastasis].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Immunologic Factors; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C | 1997 |
[Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration].
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Interleukin-12; Lung Neoplasms; Male; RNA, Messenger | 1997 |
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Survival Rate | 1997 |
[Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Middle Aged; Survival Rate | 1997 |
[Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-12; Lung Neoplasms; Male; Middle Aged; RNA, Messenger | 1998 |
[Effect of clarithromycin on experimental pulmonary metastasis].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Immunologic Factors; Killer Cells, Natural; Lung Neoplasms; Mice; Mice, Inbred C57BL | 1998 |
[Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Immunologic Factors; Lung Neoplasms; Mice; Mice, SCID; Neoplasms, Experimental | 1998 |
[Inhibitory effects of macrolide antibiotics on infiltration and proliferation of lung cancer cell lines, A-549 and SBC-3].
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Humans; Immunologic Factors; Lung Neoplasms; Tumor Cells, Cultured | 1998 |
[Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents; Beclomethasone; Bronchial Diseases; Clarithromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1998 |
[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Female; Humans; Killer Cells, Natural; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged | 1998 |
[Administration of clarithromycin (CAM) to non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clarithromycin; Disease Models, Animal; Female; Humans; Immunologic Factors; Interferon-gamma; Interleukin-10; Interleukin-12; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL | 2000 |
[Suppression of non-small-cell lung carcinoma metastasis with clarithromycin].
Topics: Aged; Animals; Anti-Bacterial Agents; Bone Neoplasms; Brain Neoplasms; Carcinoma, Small Cell; Clarithromycin; Disease Models, Animal; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Retrospective Studies | 2001 |
[Suppression of biological response to surgical stress of lung cancer resection by administration of 14-cyclol linkage macrolides].
Topics: Anti-Bacterial Agents; Biomarkers; Clarithromycin; Cytokines; Humans; Inflammation Mediators; Lung Neoplasms; Pneumonectomy; Preoperative Care; Stress, Physiological | 2001 |
[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etodolac; Lung Neoplasms; Male; Nitrosamines; Pneumonia; Rats; Rats, Wistar | 2001 |
Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.
Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Immunologic Factors; Lung Neoplasms; Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2001 |